Neopath (NPTH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neopath (NPTH)

NPTH 0.000600

0.0%

Mar 7 3:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext

To: John Zwiener who wrote ()	3/27/1997 6:30:00 PM
From: Cuong Huy Nguyen	of 178

Heya John, Autopap goes up for FDA approval again this September 20something. I think they'll get approval this time. There has been a lot of press recently about the inaccuracy about the current technology and I think in a few months more attention will focus on this industry and the harbingers of this new technology like NPTH and NSIX. Two other companies I follow are further behind in their developments for an automated process - DIGE, and ACMI. I write on the ACMI thread. ACMI is about to get approval for its TraCell product which helps cytopathologists in primary screening. It probably has about a year to go before it comes out with integrated fully-automated system like AutoPap, but it is in the works. Until then TraCell should play an important role in primary screening, until full automation becomes the norm. NPTH and ACMI are the only two of the four that are expected to make profits by 1998. NPTH's 1997 eps is projected to be a loss of ($1.22) per share, with a dramatic turnaround next year at $0.64. ACMI will lose ($0.19) this year and make $0.06-0.12 next year. Also, ACMI's 1999 earnings should be around $0.34. I don't have any figures for NPTH 1999 yet. What is your opinion as to how long it will take before complete automation is accepted by the industry? Pretty slow I think at first, since there are always going to be some people who will resist change (namely those cytopathologists who will be losing their jobs). I wonder which side the womens health advocates will take? I think political pressure will eventually convince medical practioners and the FDA to adopt the new technology and you can bet the HMO's will be pushing for a less expensive way to do pap smears. cuong

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext